Conservative medical treatment of ovarian hyperstimulation syndrome: A single center series and cost analysis study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 92, Issue 6, 2013, Pages 686-691

  Casals, Gemma ^a   Fábregues, Francisco ^a   Pavesi, Marco ^a   Arroyo, Vicente ^a   Balasch, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Conservative medical treatment; cost analysis; outpatient management; ovarian hyperstimulation syndrome

Indexed keywords

ALBUMIN; FUROSEMIDE;

ARTERY THROMBOSIS; ARTICLE; BED REST; CONSERVATIVE TREATMENT; COST BENEFIT ANALYSIS; COST OF ILLNESS; DECISION TREE; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; OVARY HYPERSTIMULATION; PARACENTESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SODIUM RESTRICTION; THROMBOEMBOLISM; VEIN THROMBOSIS;

ALBUMINS; AMBULATORY CARE; BED REST; COSTS AND COST ANALYSIS; DECISION TREES; DIET, SODIUM-RESTRICTED; DIURETICS; FEMALE; FUROSEMIDE; HEMATOCRIT; HOSPITALIZATION; HUMANS; LENGTH OF STAY; OVARIAN HYPERSTIMULATION SYNDROME; PARACENTESIS; PATIENT READMISSION; PLASMA SUBSTITUTES; PLEURAL EFFUSION; RETROSPECTIVE STUDIES; SODIUM;

EID: 84878072363     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12128     Document Type: Article

References (24)

1. Aboulghar M,. Treatment of ovarian hyperstimulation syndrome. Semin Reprod Med. 2010; 28: 532-9.
2. Aboulghar MA, Mansour RT,. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update. 2003; 9: 275-89.
3. Zivi E, Simon A, Laufer N,. Ovarian hyperstimulation syndrome: definition, incidence, and classification. Semin Reprod Med. 2010; 28: 441-7.
4. Delvigne A, Rozenberg S,. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 2003; 9: 77-96.
5. Shrivastav P, Nadkarni P, Craft I,. Day care management of severe ovarian hyperstimulation syndrome avoids hospitalization and morbidity. Hum Reprod. 1994; 9: 812-4.
6. Fluker MR, Copeland JE, Yuzpe AA,. An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome. Fertil Steril. 2000; 73: 821-4.
7. Lincoln SR, Opsahl MS, Blauer KL, Black SH, Schulman JD,. Aggressive outpatient treatment of ovarian huperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization. J Assist Reprod Genet. 2002; 19: 159-63.
8. Smith LP, Hacker MR, Alper MM,. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis. Fertil Steril. 2009; 92: 1953-9.
9. Csokmay JM, Yauger BJ, Henne MB, Armstrong AY, Queenan JT, Segars JH,. Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: 'tap early and often' versus hospitalization. Fertil Steril. 2010; 93: 167-73.
10. Balasch J, Arroyo V, Fabregues F, Salo J, Jimenez W, Pare JC, et al. Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome. Ann Intern Med. 1994; 121: 27-33.
11. Balasch J, Fabregues F, Arroyo V,. Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome. Hum Reprod. 1998; 13: 2718-30.
12. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E,. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989; 44: 430-40.
13. Skinner DC,. Introduction to decision analysis, 3rd edn. Gainesville: Probabilistic Publishing, 1999.
14. Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008; 90: S188-93.
15. Foong LC, Bhagavath B, Kumar J, Soon-Chye N,. Ovarian hyperstimulation syndrome is associated with reversible impairment of vascular reactivity. Fertil Steril. 2002; 78: 1159-63.
16. Al-Shawaf T, Grudzinskas JG,. Prevention and treatment of ovarian hyperstimulation syndrome. Best Pract Res Clin Obstet Gynaecol. 2003; 17: 249-61.
17. Chan WS,. The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol. 2009; 21: 207-18.
18. Balasch J, Arroyo V, Carmona F, Llach J, Jimenez W, Pare JC, et al. Severe ovarian hyperstimulation syndrome: role of peripheral vasodilation. Fertil Steril. 1991; 56: 1077-83.
19. Fabregues F, Balasch J, Manau D, Jimenez W, Arroyo V, Creus M, et al. Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. Hum Reprod. 1998; 13: 2406-10.
20. Ring-Larsen H, Henriksen JH, Wilken C, Clausen J, Pals H, Christensen NJ,. Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. Br Med J. 1986; 292: 1351-3.
21. Suki WN, Eknoyan G,. Physiology of diuretic action. In:, Seldin DW, Giebisch G, (eds). The kidney: physiology and pathophysiology, 2nd edn. New York: Raven Press Ltd, 1992. pp. 3629-70.
22. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010; 53: 397-417.
23. Morris RS, Paulson RJ,. Ovarian hyperstimulation syndrome: classification and management. Contemp Obstet Gyn. 1994; 12: 43-54.
24. Balasch J, Fabregues F, Arroyo V, Jimenez W, Creus M, Vanrell JA,. Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach. Acta Obstet Gynecol Scand. 1996; 75: 662-7.